Close X
Tuesday, December 3, 2024
ADVT 
International

Indian-American astronaut part of SpaceX Crew-3 mission

Darpan News Desk IANS, 07 Oct, 2021 11:35 AM
  • Indian-American astronaut part of SpaceX Crew-3 mission

Washington, Oct 7 (IANS) An Indian-American astronaut is part of NASA-SpaceX's third mission to the International Space Station.

"NASA's SpaceX Crew-3 mission will carry NASA astronauts Raja Chari, Tom Marshburn, and Kayla Barron as well as ESA (European Space Agency) astronaut Matthias Maurer aboard a Crew Dragon spacecraft on a Falcon 9 rocket to the space station," the US space agency said in a statement.

The four astronauts will lift off to space on October 30 from Launch Complex 39A at NASA's Kennedy Space Center in Florida, the statement added.

Crew-3 is the SpaceX's fifth crewed flight to space and fourth to the International Space Station.

Indian-American Chari will serve as the commander of the Crew Dragon spacecraft and the Crew-3 mission. He also will serve as an Expedition 66 flight engineer aboard the station.

Born in Milwaukee, he became a NASA astronaut in 2017 and this will be his first spaceflight. He is also a colonel in the US Air Force and has extensive experience as a test pilot with more than 2,500 hours of flight time.

The Crew-3 mission follows Inspiration4, an all-civilian crewed mission that lifted off on September 15 for an orbital journey aboard a SpaceX Crew Dragon spacecraft.

With Crew-3, "the four crew going up are going to be doing even more science," Space.com reported Kathy Leuders, associate administrator for the Space Operations Mission Directorate at NASA as saying.

Leuders added that the crew will be continuing to test "our exploration risks and pushing the bounds of technology and continuing to establish our key international partner relationships."

This expedition "will have experiments that crossover from science and utilisation that we do as well as technology development", added Joel Montalbano, the manager of NASA's ISS programme.

He specified that there will be experiments on board that include human research as well as rodent research and other experimentation similar to what's been done previously on the station.

But, while the astronauts launching will spend the vast majority of their six-month station stay working hard, they will have a bit of room for some festive fun. The crew will be arriving just in time for Halloween and will also be living in the lab during the winter holidays,the report said.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19